Stable gastric pentadecapeptide BPC 157: vascular and organoprotective effects
The peptide works best as part of a comprehensive approach addressing all aspects of recovery
The company focuses on innovation, strict quality control, and efficient distribution systems to maintain excellence in the healthcare industry
Health care providers are asked to report any suspected adverse reactions to SAHPRA via the 6.04 Adverse Drug Reactions Reporting Form , found online under SAHPRAs publications: 4.9 Overdose Sensorial neuropathy and other sensorial neuropathy syndromes which can be caused by long-term administration of high doses of pyridoxine improve gradually upon vitamin discontinuation
PMID 29543316
This peptide formulation combines GLP3, a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, with cagrilintide, a long-acting amylin analog, creating a dual-mechanism research tool that addresses metabolic dysfunction through complementary pathways